United States Medical Instruments & Supplies news

21:10 31 Jul 2026

TradingView Analyst action Main company 🇺🇸 United States

Merit Medical Systems, Inc. Stock 12‑Month Price Target Raised to $99.82, Implies 20% Upside

Merit Medical Systems, Inc.'s average 12-month price target has been increased to $99.82 from $90.09, based on estimates from 11 analysts. This updated target suggests a potential upside of approximately 20% from the July 30 closing price. The consensus rating for MMSI stock remains …

MMSI main company

Sharemaestro market context Price above Trend Line 52 weeks +1.5%

21:09 31 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Kestra Medical Technologies (KMTS) insider files to sell 8,759 shares under Rule 144

Kestra Medical Technologies insider Timothy Moran has filed a notice to sell up to 8,759 shares of common stock under Rule 144, with an aggregate market value of $198,000.29 as of July 31, 2026. These shares are from vested performance share unit awards. The …

KMTS main company

Sharemaestro market context Trend signal started 52 weeks +50.8%

21:09 31 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Kestra Medical Technologies (KMTS) insider plans $196K Rule 144 stock sale

An insider at Kestra Medical Technologies (KMTS), Alfred J Ford, plans to sell 8,681 shares of common stock under Rule 144, valued at approximately $196,284.58. The sale, expected on July 31, 2026, involves shares from performance share unit awards that vested on July 17, …

KMTS main company

Sharemaestro market context Trend signal started 52 weeks +50.8%

21:09 31 Jul 2026

Moomoo Earnings Main company 🇺🇸 United States

Earnings Flash (ATR) AptarGroup, Inc. Posts Q2 Adjusted EPS $1.42 per Share, Vs. FactSet Est of $1.35

AptarGroup, Inc. (ATR) reported its Q2 adjusted EPS of $1.42 per share, surpassing FactSet's estimate of $1.35 per share. This indicates a stronger-than-expected financial performance for the quarter.

ATR main company

Sharemaestro market context Price above Trend Line 52 weeks -5.5%

21:09 31 Jul 2026

Investing.com South Africa Market update Main company 🇺🇸 United States

Form 4 Anteris Technologies Global Corp. For: 31 July By Investing.com

This article announces the filing of Form 4 for Anteris Technologies Global Corp. for the 31st of July. Form 4 is a U.S. Securities and Exchange Commission filing used to disclose changes in beneficial ownership of a company's securities by insiders. The brief news …

AVR main company

Sharemaestro market context Trend signal active 52 weeks +126.5%

20:40 31 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Zentek Ltd (ZTEK) Institutional Confidence

This article from TradingKey focuses on the institutional confidence in Zentek Ltd (ZTEK). It highlights key shareholder activity, including the number of shares held by various institutions and individuals like Gregory Fenton, Scotia Capital Inc., and Colin Stuart Van der Kuur, along with their …

ZTEK main company

Sharemaestro market context Price above Trend Line 52 weeks -10.9% · Next-week setup negative 36.2%

18:39 31 Jul 2026

Investing.com Analyst action Main company 🇺🇸 United States

Needham raises Teleflex stock price target on FDA plasma approval

Needham has increased its price target for Teleflex (NYSE:TFX) to $159 from $147, maintaining a Buy rating, following FDA approval of the company's EZPLAZ Freeze Dried Plasma product. The stock is currently trading at $132.30, and InvestingPro suggests it is undervalued. The approval of …

TFX main company

Sharemaestro market context Trend signal active 52 weeks +6.9% · Next-week setup negative 43.9%

18:24 31 Jul 2026

Simply Wall St Guidance Main company 🇺🇸 United States

Why Baxter (BAX) Is Up 23.4% After Raising 2026 Outlook Despite Weaker First-Half Profitability

Baxter International Inc. (BAX) saw its stock rise 23.4% after reporting increased Q2 2026 sales and net income, leading to an upgraded full-year sales and earnings guidance for continuing operations. Despite this, first-half 2026 net income was lower year-over-year, indicating persistent early-year profitability pressures. …

BAX main company

Sharemaestro market context Trend signal active 52 weeks +9.8%

18:20 31 Jul 2026

Sahm Regulatory and legal Main company 🇺🇸 United States

Embecta (EMBC) Stock Drop: Robbins LLP Reminds Investors of Class Action and Urges Shareholders Who Lost Money to Contact the Firm

Robbins LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta misled investors about its financial outlook, particularly its pen needle …

EMBC main company

Sharemaestro market context New activity signal 52 weeks -63.1%

18:14 31 Jul 2026

MarketWatch Earnings Main company 🇺🇸 United States

Align Technology Inc. stock underperforms Friday when compared to competitors

Align Technology Inc. (ALGN) shares fell by 2.45% on Friday, closing at $169.16. This underperformance occurred despite a positive trading session for the broader market, with the S&P 500 Index and Dow Jones Industrial Average both seeing gains. This marks the second consecutive day …

ALGN main company

Sharemaestro market context Price above Trend Line 52 weeks +21.2%

18:12 31 Jul 2026

MarketWatch Market update Main company 🇺🇸 United States

Baxter International Inc. stock underperforms Friday when compared to competitors

Shares of Baxter International Inc. (BAX) fell by 2.21% on Friday, closing at $26.16, despite an overall positive trading session for the stock market. This decline broke a five-day winning streak for the company's stock. The S&P 500 Index and the Dow Jones Industrial …

BAX main company

Sharemaestro market context Trend signal active 52 weeks +9.8%

18:11 31 Jul 2026

MarketWatch Earnings Main company 🇺🇸 United States

Solventum Corp. stock falls Friday, underperforms market

Solventum Corp. (SOLV) stock fell 1.59% on Friday, closing at $85.44, and underperformed the broader market, which saw the S&P 500 Index and Dow Jones Industrial Average rise. This marks the second consecutive day of losses for Solventum.

SOLV main company

Sharemaestro market context Trend signal active 52 weeks +20.4% · Next-week setup negative 34.7%

17:41 31 Jul 2026

AD HOC NEWS Earnings Main company 🇺🇸 United States

Alcon stock trades steadily as surgical and vision care growth supports earnings

Alcon stock demonstrates stable fundamentals, supported by increasing revenue and operating income from its surgical and vision care segments. The company's diversified portfolio, including ophthalmic surgery systems and contact lenses, drives recurring sales and strong cash flow. Investors are focused on segment growth rates, …

ALC main company

Sharemaestro market context Price above Trend Line 52 weeks -8.4%

17:40 31 Jul 2026

Stock Titan Deals and strategy Main company 🇺🇸 United States

OraSure Technologies (OSUR) investor discloses 5.5% stake in common stock

Private Management Group, Inc., an investment adviser, has disclosed a 5.5% beneficial ownership stake in OraSure Technologies Inc. (OSUR) common stock, totaling 3,797,682 shares as of June 30, 2026. The firm holds sole voting and dispositive power over these shares, which are managed across …

OSUR main company

Sharemaestro market context Trend signal active 52 weeks +28.0% · Next-week setup negative 40.2%

17:09 31 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Precision Optics Corporation, Inc. Revenue Breakdown – NASDAQ:POCI

Precision Optics Corporation, Inc. (NASDAQ: POCI) generated the majority of its revenue from the United States, contributing $19.09 million USD last year and $19.10 million USD the year prior. This data highlights the company's primary market for its revenue streams. The information is provided …

POCI main company

Sharemaestro market context Price below Trend Line 52 weeks -11.4%

16:42 31 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

OraSure Technologies Inc (OSUR) Financial Health: Profitability & Balance Sheet Analysis

OraSure Technologies Inc (OSUR) currently holds a financial score of 6.97, placing it 116th out of 199 companies in the Healthcare Equipment & Supplies industry. While its financial status is deemed robust, its operational efficiency is low. The company recently reported a quarterly revenue …

OSUR main company

Sharemaestro market context Trend signal active 52 weeks +28.0% · Next-week setup negative 40.2%

16:41 31 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Zentek (NASDAQ: ZTEK) folds U.S. graphite JV press release into Form F-3

Zentek Ltd. filed an amendment to its Form 6-K to incorporate a June 26, 2026 press release into its Registration Statement on Form F-3. This press release announced the formation of a U.S. joint venture focused on positioning Zentek's Albany ultra-high-purity graphite in the …

ZTEK main company

Sharemaestro market context Price above Trend Line 52 weeks -10.9% · Next-week setup negative 36.2%

16:41 31 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Zentek (ZTEK) links ZenGuard U.S. sales press release to Form F-3

Zentek Ltd. filed an amendment to its Form 6-K to incorporate a press release regarding its ZenGuard™ Enhanced Air Filtration Media U.S. sales pathway into its Form F-3 Registration Statement. This amendment ensures that the press release, initially furnished on June 29, 2026, is …

ZTEK main company

Sharemaestro market context Price above Trend Line 52 weeks -10.9% · Next-week setup negative 36.2%

16:39 31 Jul 2026

Market source Earnings Main company 🇺🇸 United States

AptarGroup Q2 Earnings Call Highlights

AptarGroup reported record Q2 sales of $1 billion, up 6% year-over-year, with adjusted EPS of $1.42 exceeding guidance, primarily driven by strong Pharma segment performance. However, adjusted EBITDA declined 3% and margins faced pressure due to weaker emergency medicine sales, operating challenges, and higher …

ATR main company

Sharemaestro market context Price above Trend Line 52 weeks -5.5%

15:46 31 Jul 2026

Stock Titan Deals and strategy Main company 🇺🇸 United States

Vanguard Capital Management reports 5% Repligen (RGEN) stake in Schedule 13G

Vanguard Capital Management has disclosed a 5% beneficial ownership stake in Repligen Corp (RGEN) through a Schedule 13G filing. This represents 2,825,579 shares of common stock, with Vanguard holding sole voting power over 414,408 shares and sole dispositive power over all 2,825,579 shares. The …

RGEN main company

Sharemaestro market context Trend signal active 52 weeks +33.7%

15:41 31 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Zentek Ltd. (ZTEK) folds ZenGuard patent release into Form F-3 shelf

Zentek Ltd. has filed an amended foreign issuer report (Form 6-K/A) to incorporate a previous press release regarding its ZenGuard™ Graphene-based Technology patent into its Form F-3 shelf registration. This amendment clarifies how the patent disclosure interacts with the company's U.S. registration statement, allowing …

ZTEK main company

Sharemaestro market context Price above Trend Line 52 weeks -10.9% · Next-week setup negative 36.2%

15:40 31 Jul 2026

Bitget Analyst action Main company 🇺🇸 United States

MERIT MEDICAL SYSTEMS, INC. : WELLS FARGO RAISES TARGET PRICE TO $83 FROM $74

Wells Fargo has increased its target price for MERIT MEDICAL SYSTEMS, INC. (MMSI.O) to $83 from $74. This update was reported by Reuters on July 31, 2026. The article states that the content reflects the author's opinion and is not investment advice.

MMSI main company

Sharemaestro market context Price above Trend Line 52 weeks +1.5%

15:39 31 Jul 2026

Benzinga Earnings Main company 🇺🇸 United States

Board Member At AtriCure Exercises Options Worth $491K

Sven Wehrwein, a Board Member at AtriCure (NASDAQ: ATRC), exercised stock options worth $491,500 for 25,000 shares on July 30, according to an SEC filing. Despite the insider transaction, AtriCure shares were down by 6.06% on Friday morning. The article also provides a financial …

ATRC main company

Sharemaestro market context Trend signal started 52 weeks +17.6%

15:10 31 Jul 2026

Moomoo Earnings Main company 🇺🇸 United States

Merit Medical Systems Q2 Non-GAAP Earnings, Net Sales Rise; Lifts 2026 Guidance

Merit Medical Systems reported increased non-GAAP earnings and net sales for Q2, leading the company to raise its financial guidance for 2026. This positive performance indicates strong operational results and an optimistic outlook for the coming year.

MMSI main company

Sharemaestro market context Price above Trend Line 52 weeks +1.5%

15:10 31 Jul 2026

KVUE Earnings Main company 🇺🇸 United States

Merit Medical: Q2 Earnings Snapshot

This article provides a brief snapshot of Merit Medical's Q2 earnings. Due to the lack of detailed financial information, specific figures or performance metrics cannot be reported in the summary.

MMSI main company

Sharemaestro market context Price above Trend Line 52 weeks +1.5%

14:55 31 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Avantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy?

Avantor, Inc. (AVTR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AVTR's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross." A golden cross is …

AVTR main company

Sharemaestro market context Trend signal active 52 weeks +2.9%

14:38 31 Jul 2026

TradingView Deals and strategy Main company 🇺🇸 United States

Resmed's Q4 Earnings on Deck: What's in Store for the Stock?

Resmed (RMD) is scheduled to release its fourth-quarter fiscal 2026 results on August 6, with analysts projecting an 8.4% revenue increase to $1.46 billion and a 13.7% rise in EPS to $2.90. The company's Sleep and Breathing Health segment is expected to drive growth …

RMD main company

Sharemaestro market context Price above Trend Line 52 weeks -23.0%

14:10 31 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Canaccord raises Merit Medical stock price target on strong Q2 results

Canaccord increased its price target for Merit Medical Systems (NASDAQ:MMSI) to $94 from $85, maintaining a Buy rating after the company reported strong second-quarter results. Merit Medical surpassed revenue and EPS estimates, showing 10% year-over-year revenue growth and its strongest organic growth in three …

MMSI main company

Sharemaestro market context Price above Trend Line 52 weeks +1.5%

13:39 31 Jul 2026

TradingView Market update Main company 🇺🇸 United States

Anteris Technologies Global requests ASX trading halt after late CDI cleansing notice

Anteris Technologies Global requested an ASX trading halt because it failed to lodge a cleansing notice for 44,068 CHESS Depositary Interests (CDIs) issued on July 10, 2026, within the required five business days. The company plans to lodge the notice late and seek Federal …

AVR main company

Sharemaestro market context Trend signal active 52 weeks +126.5%

13:39 31 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Late CDI notice sends Anteris Technologies (NASDAQ: AVR) to court

Anteris Technologies (NASDAQ: AVR) requested a trading halt on the Australian Securities Exchange due to an administrative oversight in lodging a cleansing notice for 44,068 CHESS Depositary Interests (CDIs) issued on July 10, 2026. The company plans to seek relief from the Federal Court …

AVR main company

Sharemaestro market context Trend signal active 52 weeks +126.5%

13:11 31 Jul 2026

Moomoo Analyst action Main company 🇺🇸 United States

Needham Raises Price Target on Teleflex to $159 From $147, Keeps Buy Rating

Needham has increased its price target for Teleflex (TFX) to $159 from $147, while maintaining a Buy rating on the stock. This adjustment reflects Needham's continued positive outlook on the company's financial prospects and market position.

TFX main company

Sharemaestro market context Trend signal active 52 weeks +6.9% · Next-week setup negative 43.9%

13:09 31 Jul 2026

The Globe and Mail Analyst action Provider-linked mention 🇺🇸 United States

Canaccord Genuity Keeps Their Buy Rating on Pulse Biosciences (PLSE)

Canaccord Genuity analyst William Plovanic reiterated a Buy rating on Pulse Biosciences (PLSE) and set a price target of $32.00. This follows Oppenheimer also maintaining a Buy rating with a $35.00 price target. The company recently reported a quarterly revenue of $401 thousand and …

PLSE mentioned

Sharemaestro market context Trend signal active 52 weeks +161.2%

13:07 31 Jul 2026

Moomoo Analyst action Main company 🇺🇸 United States

Deutsche Bank Adjusts Baxter International PT to $27 From $20, Maintains Hold Rating

Deutsche Bank has adjusted its price target for Baxter International (NYSE: BAX) to $27, an increase from the previous target of $20. The firm has decided to maintain its Hold rating on the stock.

BAX main company

Sharemaestro market context Trend signal active 52 weeks +9.8%

13:07 31 Jul 2026

Revelio Labs Earnings Main company 🇺🇸 United States

Align Technology Number of Employees 2026 | Employee Count & Headcount Data

Align Technology (NASDAQ: ALGN) had approximately 20,427 employees worldwide as of March 2026, representing an 8.2% decline since 2023. The company is actively hiring, with 829 active job postings in 2026, a 21.7% increase from the previous year. While overall employee sentiment is neutral …

ALGN main company

Sharemaestro market context Price above Trend Line 52 weeks +21.2%

12:10 31 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

ICU Medical Inc (ICUI) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of ICU Medical Inc (ICUI), noting its current valuation score of 8.38, ranking 90th in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of 89.70 and mentions that relevant data for P/B, P/S, and …

ICUI main company

Sharemaestro market context Trend signal active 52 weeks +42.8%

11:39 31 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

L1 Capital funds sell 714,138 Anteris Technologies Global Corp. (AVR)

Funds managed by L1 Capital Pty Ltd, a 10% owner of Anteris Technologies Global Corp. (AVR), recently sold a total of 714,138 shares of common stock. These sales occurred on July 29 and 30, 2026, with prices ranging from $8.03 to $8.20 per share, …

AVR main company

Sharemaestro market context Trend signal active 52 weeks +126.5%